INTERLEUKIN-3

INTERLEUKIN-3 was reported 359 times

INTERLEUKIN-3 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALBUMIN CSF INCREASED 1 0.0667
1 ADMINISTRATION SITE ULCER 1 0.0417
2 HAEMANGIOMA-THROMBOCYTOPENIA SYNDROME 1 0.0385
3 BILIARY ANASTOMOSIS COMPLICATION 4 0.0333
4 PERI-IMPLANTITIS 2 0.0225
5 ATRIAL SEPTAL DEFECT ACQUIRED 1 0.0192
6 LYMPHOCYTIC HYPOPHYSITIS 5 0.0181
7 GRANULOMATOUS DERMATITIS 4 0.0164
8 NEUROBLASTOMA 6 0.0157
9 CARDIAC NEOPLASM MALIGNANT 1 0.0141
10 AUTOIMMUNE DERMATITIS 2 0.0132
11 TOOTH AVULSION 2 0.0114
12 ACUTE BIPHENOTYPIC LEUKAEMIA 1 0.0108
13 ADENOVIRUS TEST POSITIVE 1 0.0105
14 MELANOSIS 1 0.0089
15 ABDOMINAL REBOUND TENDERNESS 1 0.0089
16 MEGAKARYOCYTES INCREASED 1 0.0081
17 PERIPORTAL OEDEMA 1 0.0080
18 SKIN DEPIGMENTATION 10 0.0073
19 PNEUMATOSIS 3 0.0067
20 ANGIOSARCOMA 3 0.0065
21 AUTOIMMUNE ARTHRITIS 1 0.0064
22 METASTASES TO MUSCLE 1 0.0055
23 PANCREAS TRANSPLANT REJECTION 1 0.0050
24 CAPILLARY LEAK SYNDROME 10 0.0048
25 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
26 MUCOSAL INFECTION 1 0.0043
27 KERATOSIS PILARIS 1 0.0040
28 FINE MOTOR DELAY 1 0.0039
29 METASTASES TO SOFT TISSUE 1 0.0039
30 SHORT STATURE 1 0.0038
31 PARAPSORIASIS 1 0.0037
32 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
33 METASTASES TO KIDNEY 2 0.0036
34 ENTEROBACTER BACTERAEMIA 1 0.0033
35 METASTASES TO SKIN 3 0.0029
36 PORTAL VENOUS GAS 1 0.0028
37 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
38 OTOTOXICITY 5 0.0027
39 CARDIOTOXICITY 22 0.0025
40 APPLICATION SITE DISCOLOURATION 10 0.0025
41 CLUBBING 1 0.0025
42 METASTASES TO SPLEEN 1 0.0024
43 FISTULA OF SMALL INTESTINE 1 0.0024
44 HAEMANGIOMA OF SKIN 1 0.0023
45 METASTASES TO PANCREAS 1 0.0023
46 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
47 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
48 CEREBRAL TOXOPLASMOSIS 2 0.0021
49 ADRENAL NEOPLASM 1 0.0021
50 VITILIGO 5 0.0021
51 ECZEMA ASTEATOTIC 1 0.0021
52 VENOOCCLUSIVE DISEASE 5 0.0020
53 POOR PERSONAL HYGIENE 1 0.0019
54 POSTICTAL STATE 2 0.0019
55 BONE CANCER METASTATIC 1 0.0019
56 PERIORBITAL CELLULITIS 1 0.0019
57 KLEBSIELLA SEPSIS 2 0.0018
58 MOTOR DEVELOPMENTAL DELAY 1 0.0017
59 NERVE ROOT COMPRESSION 1 0.0017
60 MEDIASTINITIS 1 0.0017
61 PANNICULITIS 4 0.0017
62 POST PROCEDURAL DISCHARGE 1 0.0015
63 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
64 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
65 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
66 LIVEDO RETICULARIS 3 0.0014
67 RETINAL VEIN THROMBOSIS 1 0.0014
68 MYELITIS TRANSVERSE 2 0.0014
69 GASTRIC MUCOSAL LESION 1 0.0014
70 SKIN EROSION 4 0.0012
71 VASCULAR ACCESS COMPLICATION 1 0.0012
72 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
73 CSF PROTEIN INCREASED 1 0.0012
74 DYSCHROMATOPSIA 1 0.0012
75 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
76 ENZYME LEVEL INCREASED 1 0.0012
77 ENTEROVIRUS INFECTION 1 0.0012
78 HAEMORRHAGIC ANAEMIA 5 0.0011
79 RENAL TUBULAR ATROPHY 1 0.0011
80 METASTATIC RENAL CELL CARCINOMA 2 0.0011
81 INJECTION SITE ULCER 1 0.0011
82 LIPOATROPHY 1 0.0011
83 RED BLOOD CELLS URINE POSITIVE 1 0.0010
84 BLADDER CATHETERISATION 1 0.0010
85 RENAL CELL CARCINOMA 5 0.0010
86 SUBILEUS 2 0.0010
87 METASTASES TO PLEURA 1 0.0010
88 TUMOUR NECROSIS 1 0.0009
89 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
90 TUMOUR PSEUDOPROGRESSION 1 0.0009
91 BENIGN NEOPLASM 1 0.0009
92 BLOOD LOSS ANAEMIA 2 0.0009
93 METASTATIC MALIGNANT MELANOMA 2 0.0009
94 METASTASES TO LUNG 10 0.0009
95 RADIATION SKIN INJURY 1 0.0009
96 PAROTITIS 1 0.0009
97 METABOLIC DISORDER 5 0.0009
98 BILE DUCT STENOSIS 1 0.0008
99 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
100 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
101 METASTASES TO PERITONEUM 2 0.0008
102 NEPHRITIS INTERSTITIAL 1 0.0008
103 NOCARDIOSIS 2 0.0008
104 ADENOCARCINOMA PANCREAS 1 0.0008
105 IMMUNE RECONSTITUTION SYNDROME 1 0.0008
106 TRANSITIONAL CELL CARCINOMA 1 0.0008
107 CYSTITIS NONINFECTIVE 1 0.0007
108 BRONCHIECTASIS 5 0.0007
109 VIRAEMIA 1 0.0007
110 INTRACRANIAL PRESSURE INCREASED 4 0.0007
111 GENITAL RASH 1 0.0007
112 SMALL CELL LUNG CANCER 1 0.0007
113 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
114 OLIGURIA 4 0.0006
115 NEOPLASM SKIN 1 0.0006
116 HYPOALBUMINAEMIA 5 0.0006
117 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
118 OVARIAN CANCER RECURRENT 1 0.0006
119 GUILLAIN-BARRE SYNDROME 3 0.0006
120 ACUTE LEUKAEMIA 1 0.0006
121 INJECTION SITE INFLAMMATION 3 0.0006
122 METASTASES TO SPINE 2 0.0006
123 MALIGNANT PLEURAL EFFUSION 1 0.0006
124 LEUKAEMIA RECURRENT 1 0.0006
125 BONE MARROW FAILURE 12 0.0006
126 EJECTION FRACTION DECREASED 9 0.0006
127 SPLENIC INFARCTION 1 0.0006
128 PNEUMONIA KLEBSIELLA 1 0.0005
129 PUPILLARY REFLEX IMPAIRED 1 0.0005
130 INJECTION SITE CELLULITIS 1 0.0005
131 TRAUMATIC LUNG INJURY 1 0.0005
132 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
133 OPTIC NEUROPATHY 1 0.0005
134 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
135 JAW FRACTURE 1 0.0005
136 PARESIS 1 0.0004
137 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
138 METASTASES TO MENINGES 1 0.0004
139 PULMONARY TOXICITY 3 0.0004
140 CONTRAST MEDIA REACTION 1 0.0004
141 PROTEINURIA 8 0.0004
142 KIDNEY TRANSPLANT REJECTION 2 0.0004
143 METASTASES TO LIVER 7 0.0004
144 ABDOMINAL INFECTION 1 0.0004
145 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
146 RESPIRATORY DISTRESS 10 0.0004
147 MACULE 1 0.0004
148 NECROSIS 2 0.0004
149 SERUM SICKNESS 1 0.0004
150 LUNG CONSOLIDATION 1 0.0004
151 TUMOUR HAEMORRHAGE 1 0.0004
152 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
153 URINE OUTPUT DECREASED 3 0.0003
154 STRIDOR 1 0.0003
155 URINE ANALYSIS ABNORMAL 1 0.0003
156 DERMATITIS ACNEIFORM 2 0.0003
157 DYSCHEZIA 1 0.0003
158 FIBROSIS 1 0.0003
159 MULTIPLE-DRUG RESISTANCE 1 0.0003
160 NON-CARDIAC CHEST PAIN 1 0.0003
161 POSTURE ABNORMAL 1 0.0003
162 BACTERIAL SEPSIS 1 0.0003
163 METASTASES TO BONE 5 0.0003
164 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
165 SKIN MASS 2 0.0003
166 MENINGITIS 2 0.0003
167 BK VIRUS INFECTION 1 0.0003
168 METASTASES TO LYMPH NODES 2 0.0003
169 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
170 TACHYPNOEA 4 0.0003
171 HYPERBILIRUBINAEMIA 3 0.0003
172 BLOOD CREATININE ABNORMAL 1 0.0003
173 GRANULOMA 1 0.0003
174 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
175 HYPOXIA 10 0.0003
176 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
177 LYMPHOPENIA 4 0.0003
178 METASTASIS 2 0.0003
179 GRAFT VERSUS HOST DISEASE 2 0.0003
180 BONE LESION 1 0.0003
181 SCLERODERMA 1 0.0003
182 HYPOPHOSPHATAEMIA 2 0.0003
183 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
184 EYELID OEDEMA 3 0.0003
185 PULMONARY HAEMORRHAGE 2 0.0003
186 BLOOD ALBUMIN DECREASED 2 0.0003
187 ARTHRITIS BACTERIAL 1 0.0002
188 ANAPHYLACTOID REACTION 1 0.0002
189 HYPERCALCAEMIA 3 0.0002
190 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
191 EMBOLISM 2 0.0002
192 SECOND PRIMARY MALIGNANCY 2 0.0002
193 BLOOD UREA INCREASED 4 0.0002
194 DERMATITIS 5 0.0002
195 LUNG NEOPLASM 1 0.0002
196 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
197 BONE CANCER 1 0.0002
198 MELANOCYTIC NAEVUS 1 0.0002
199 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
200 DISEASE COMPLICATION 1 0.0002
201 PNEUMONIA BACTERIAL 2 0.0002
202 ISCHAEMIA 1 0.0002
203 PERFORMANCE STATUS DECREASED 1 0.0002
204 CARDIAC TAMPONADE 1 0.0002
205 PULSE ABSENT 1 0.0002
206 BRONCHOSPASM 3 0.0002
207 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
208 GASTROINTESTINAL TOXICITY 1 0.0002
209 HUMERUS FRACTURE 1 0.0002
210 BREATH SOUNDS ABNORMAL 1 0.0002
211 OSTEONECROSIS OF JAW 5 0.0002
212 FLUID INTAKE REDUCED 1 0.0002
213 CEREBRAL ISCHAEMIA 1 0.0002
214 SKIN NECROSIS 1 0.0002
215 POLYARTHRITIS 1 0.0002
216 HYPOTHYROIDISM 6 0.0002
217 CHILLS 22 0.0002
218 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
219 NORMAL NEWBORN 1 0.0002
220 JAW DISORDER 1 0.0002
221 HYPERKERATOSIS 1 0.0002
222 COAGULOPATHY 3 0.0002
223 HEPATOTOXICITY 4 0.0002
224 MACULAR OEDEMA 1 0.0002
225 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
226 NEUROTOXICITY 3 0.0002
227 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
228 FEBRILE NEUTROPENIA 11 0.0002
229 HYPOTENSION 32 0.0002
230 HERPES SIMPLEX 1 0.0002
231 ASPERGILLUS INFECTION 1 0.0002
232 DISEASE PROGRESSION 18 0.0002
233 MALIGNANT MELANOMA 2 0.0001
234 COLITIS ISCHAEMIC 1 0.0001
235 NEPHROTIC SYNDROME 1 0.0001
236 INFLUENZA LIKE ILLNESS 12 0.0001
237 PULMONARY HYPERTENSION 3 0.0001
238 AUTOIMMUNE HEPATITIS 1 0.0001
239 PANCYTOPENIA 8 0.0001
240 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
241 NEUTROPENIC SEPSIS 1 0.0001
242 PARALYSIS 2 0.0001
243 FLUID OVERLOAD 2 0.0001
244 RESPIRATORY FAILURE 10 0.0001
245 RASH MACULO-PAPULAR 3 0.0001
246 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
247 PEMPHIGOID 1 0.0001
248 COLITIS 5 0.0001
249 ACIDOSIS 1 0.0001
250 DEVICE RELATED INFECTION 2 0.0001
251 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
252 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
253 ULCER 2 0.0001
254 DECUBITUS ULCER 1 0.0001
255 HEMIPLEGIA 1 0.0001
256 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
257 SKIN PLAQUE 1 0.0001
258 SKIN ULCER 3 0.0001
259 MYOPATHY 1 0.0001
260 PYELONEPHRITIS 1 0.0001
261 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
262 DEAFNESS 3 0.0001
263 TUMOUR LYSIS SYNDROME 1 0.0001
264 LYMPHOCYTE COUNT DECREASED 2 0.0001
265 HAEMOLYTIC ANAEMIA 1 0.0001
266 SYNOVITIS 2 0.0001
267 LEUKOCYTOSIS 2 0.0001
268 PNEUMONITIS 3 0.0001
269 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
270 MENTAL STATUS CHANGES 3 0.0001
271 ATELECTASIS 1 0.0001
272 THROMBOTIC MICROANGIOPATHY 1 0.0001
273 HEPATOMEGALY 1 0.0001
274 BRAIN INJURY 1 0.0001
275 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
276 APHASIA 3 0.0001
277 THROMBOCYTOPENIA 11 0.0001
278 PYREXIA 34 0.0001
279 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
280 NEUTROPHIL COUNT INCREASED 1 0.0001
281 TRANSFUSION 1 0.0001
282 SUDDEN DEATH 1 0.0001
283 OEDEMA 5 0.0001
284 BLOOD CREATININE INCREASED 6 0.0001
285 TACHYCARDIA 8 0.0001
286 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
287 PULMONARY OEDEMA 4 0.0001
288 ANAEMIA 17 0.0001
289 NEPHROPATHY TOXIC 1 0.0001
290 STATUS EPILEPTICUS 1 0.0001
291 HYPERLIPIDAEMIA 1 0.0001
292 HEPATITIS C 1 0.0001
293 INTERSTITIAL LUNG DISEASE 4 0.0001
294 OEDEMA PERIPHERAL 10 0.0001
295 DECREASED APPETITE 19 0.0001
296 ENCEPHALOPATHY 2 0.0001
297 SMALL INTESTINAL OBSTRUCTION 1 0.0001
298 NEUTROPENIA 11 0.0001
299 GENERALISED OEDEMA 1 0.0001
300 ILEUS 1 0.0001
301 PNEUMONIA ASPIRATION 2 0.0001
302 HYPOPHAGIA 2 0.0001
303 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
304 MYDRIASIS 1 0.0001
305 NODULE 1 0.0001
306 MUCOSAL INFLAMMATION 2 0.0001
307 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
308 JAUNDICE 2 0.0001
309 BLOOD BILIRUBIN INCREASED 2 0.0001
310 GINGIVAL BLEEDING 1 0.0001
311 TREATMENT FAILURE 6 0.0001
312 HYPOMAGNESAEMIA 1 0.0001
313 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
314 DRUG INTERACTION 11 0.0001
315 MYELODYSPLASTIC SYNDROME 1 0.0001
316 INFECTION 10 0.0001
317 HYPERTHYROIDISM 1 0.0001
318 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
319 RENAL INJURY 2 0.0001
320 PULMONARY MASS 1 0.0001
321 HAEMORRHAGE INTRACRANIAL 1 0.0001
322 THERAPY NON-RESPONDER 3 0.0001
323 BONE LOSS 1 0.0001
324 EPILEPSY 2 0.0001
325 HYPOKALAEMIA 3 0.0001
326 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
327 LUNG INFECTION 1 0.0001
328 ACUTE MYELOID LEUKAEMIA 1 0.0001
329 THERAPY PARTIAL RESPONDER 1 0.0001
330 NERVOUS SYSTEM DISORDER 2 0.0001
331 PRODUCT USE ISSUE 12 0.0001
332 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
333 PNEUMOTHORAX 1 0.0001
334 PRODUCTIVE COUGH 3 0.0001
335 OFF LABEL USE 54 0.0001
336 VENTRICULAR TACHYCARDIA 1 0.0001
337 PHOTOSENSITIVITY REACTION 1 0.0001
338 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
339 CYTOMEGALOVIRUS INFECTION 1 0.0001
340 URINARY RETENTION 2 0.0001
341 TOXICITY TO VARIOUS AGENTS 10 0.0001
342 FACE OEDEMA 1 0.0001
343 EOSINOPHILIA 1 0.0001
344 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
345 PLATELET COUNT DECREASED 6 0.0001
346 GOUT 1 0.0001
347 GASTROENTERITIS VIRAL 1 0.0001
348 RASH PRURITIC 3 0.0001
349 BONE DISORDER 1 0.0001
350 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
351 SEPSIS 6 0.0001
352 HYPONATRAEMIA 3 0.0001
353 PHOTOPHOBIA 1 0.0001
354 GASTRIC ULCER 1 0.0001
355 ACUTE RESPIRATORY FAILURE 1 0.0001
356 GLAUCOMA 1 0.0001
357 HAEMATOCRIT DECREASED 1 0.0001
358 STOMATITIS 3 0.0000
359 NEUTROPHIL COUNT DECREASED 2 0.0000
360 CARDIAC ARREST 4 0.0000
361 RHABDOMYOLYSIS 2 0.0000
362 LIVER FUNCTION TEST INCREASED 1 0.0000
363 DEEP VEIN THROMBOSIS 3 0.0000
364 FAECES DISCOLOURED 1 0.0000
365 PRODUCT PRESCRIBING ISSUE 1 0.0000
366 MELAENA 1 0.0000
367 STEVENS-JOHNSON SYNDROME 1 0.0000
368 TRANSAMINASES INCREASED 1 0.0000
369 ORAL PAIN 1 0.0000
370 CHROMATURIA 1 0.0000
371 ARRHYTHMIA 2 0.0000
372 PULMONARY EMBOLISM 4 0.0000
373 NEUROPATHY PERIPHERAL 4 0.0000
374 PRESYNCOPE 1 0.0000
375 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
376 ABDOMINAL PAIN LOWER 1 0.0000
377 FLUID RETENTION 2 0.0000
378 DRUG RESISTANCE 1 0.0000
379 ERYTHEMA 8 0.0000
380 INFLAMMATION 2 0.0000
381 RESPIRATORY TRACT INFECTION 1 0.0000
382 SEDATION 1 0.0000
383 BRADYCARDIA 2 0.0000
384 DEHYDRATION 5 0.0000
385 PNEUMONIA 12 0.0000
386 SKIN LESION 1 0.0000
387 RESPIRATORY ARREST 1 0.0000
388 DIVERTICULITIS 1 0.0000
389 RENAL IMPAIRMENT 3 0.0000
390 OXYGEN SATURATION DECREASED 2 0.0000
391 MUSCULAR WEAKNESS 4 0.0000
392 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
393 LETHARGY 2 0.0000
394 ASCITES 1 0.0000
395 PRURITUS 13 0.0000
396 WHEEZING 2 0.0000
397 BLOOD POTASSIUM DECREASED 1 0.0000
398 HEPATIC FAILURE 1 0.0000
399 VOMITING 15 0.0000
400 DRUG-INDUCED LIVER INJURY 1 0.0000
401 CYSTITIS 1 0.0000
402 WEIGHT INCREASED 7 0.0000
403 MOVEMENT DISORDER 1 0.0000
404 ATRIAL FIBRILLATION 3 0.0000
405 CHOLELITHIASIS 1 0.0000
406 IMPAIRED HEALING 1 0.0000
407 OSTEONECROSIS 1 0.0000
408 STAPHYLOCOCCAL INFECTION 1 0.0000
409 VISUAL ACUITY REDUCED 1 0.0000
410 FATIGUE 23 0.0000
411 DIARRHOEA 19 0.0000
412 HAEMOGLOBIN DECREASED 3 0.0000
413 HAEMATURIA 1 0.0000
414 NAUSEA 23 0.0000
415 HYPERKALAEMIA 1 0.0000
416 HYPERTENSION 6 0.0000
417 LYMPHADENOPATHY 1 0.0000
418 CEREBRAL HAEMORRHAGE 1 0.0000
419 C-REACTIVE PROTEIN INCREASED 1 0.0000
420 HYPERGLYCAEMIA 1 0.0000
421 DYSURIA 1 0.0000
422 EPISTAXIS 2 0.0000
423 DYSPNOEA EXERTIONAL 1 0.0000
424 INTESTINAL OBSTRUCTION 1 0.0000
425 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
426 ABDOMINAL PAIN 6 0.0000
427 DISORIENTATION 1 0.0000
428 CONFUSIONAL STATE 4 0.0000
429 DYSKINESIA 1 0.0000
430 BLINDNESS 1 0.0000
431 SKIN EXFOLIATION 2 0.0000
432 CEREBROVASCULAR ACCIDENT 4 0.0000
433 MYALGIA 4 0.0000
434 SEPTIC SHOCK 1 0.0000
435 MENTAL DISORDER 1 0.0000
436 CONSTIPATION 5 0.0000
437 MUSCULOSKELETAL STIFFNESS 2 0.0000
438 ANGIOEDEMA 1 0.0000
439 DRY SKIN 3 0.0000
440 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
441 CHEST PAIN 4 0.0000
442 WEIGHT DECREASED 6 0.0000
443 DISEASE RECURRENCE 1 0.0000
444 LEUKOPENIA 1 0.0000
445 SYNCOPE 2 0.0000
446 SOMNOLENCE 4 0.0000
447 ACUTE KIDNEY INJURY 3 0.0000
448 DYSPNOEA 11 0.0000
449 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
450 MUSCULOSKELETAL PAIN 1 0.0000
451 ASTHENIA 7 0.0000
452 URTICARIA 3 0.0000
453 PAIN 11 0.0000
454 BLISTER 1 0.0000
455 FLATULENCE 1 0.0000
456 BACK PAIN 4 0.0000
457 DYSPHONIA 1 0.0000
458 PALPITATIONS 2 0.0000
459 BONE PAIN 1 0.0000
460 PAIN IN EXTREMITY 5 0.0000
461 PLEURAL EFFUSION 1 0.0000
462 DEATH 14 0.0000
463 RASH 7 0.0000
464 AMNESIA 1 0.0000
465 NEOPLASM MALIGNANT 1 0.0000
466 HEPATIC ENZYME INCREASED 1 0.0000
467 ARTHRALGIA 6 0.0000
468 COUGH 4 0.0000
469 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
470 DYSGEUSIA 1 0.0000
471 UNEVALUABLE EVENT 1 0.0000
472 DEPRESSION 3 0.0000
473 CONDITION AGGRAVATED 4 0.0000
474 DIABETES MELLITUS 1 0.0000
475 ARTHRITIS 1 0.0000
476 INJECTION SITE BRUISING 1 0.0000
477 INJECTION SITE HAEMORRHAGE 1 0.0000
478 THROMBOSIS 1 0.0000
479 DRY MOUTH 1 0.0000
480 ABDOMINAL DISCOMFORT 2 0.0000
481 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
482 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
483 ADVERSE EVENT 1 0.0000
484 SWELLING 1 0.0000
485 DRUG INTOLERANCE 1 0.0000
486 ABDOMINAL DISTENSION 1 0.0000
487 HAEMORRHAGE 1 0.0000
488 MALAISE 4 0.0000
489 DRUG INEFFECTIVE 12 0.0000
490 SEIZURE 1 0.0000
491 JOINT SWELLING 1 0.0000
492 VISUAL IMPAIRMENT 1 0.0000
493 INJECTION SITE ERYTHEMA 1 0.0000
494 HYPERHIDROSIS 1 0.0000
495 INSOMNIA 2 0.0000
496 HYPOAESTHESIA 1 0.0000
497 BLOOD PRESSURE INCREASED 1 0.0000
498 HEADACHE 4 0.0000
499 PARAESTHESIA 1 0.0000
500 URINARY TRACT INFECTION 1 0.0000
501 MYOCARDIAL INFARCTION 1 0.0000
502 HYPERSENSITIVITY 1 0.0000
503 GAIT DISTURBANCE 1 0.0000
504 ALOPECIA 1 0.0000
505 ABDOMINAL PAIN UPPER 1 0.0000
506 DIZZINESS 1 0.0000